Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Status: Enrolling
Updated:  8/28/2017
McLean Hospital
mi
from
Belmont, MA
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Status: Enrolling
Updated: 8/28/2017
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Status: Enrolling
Updated:  8/28/2017
Massachusetts General Hospital
mi
from
Boston, MA
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Status: Enrolling
Updated: 8/28/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression
Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression
Status: Enrolling
Updated:  8/28/2017
New York State Psychiatric Institute
mi
from
New York, NY
Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression
Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression
Status: Enrolling
Updated: 8/28/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
The Neurobiology of Approach Avoidance Training in Depression
The Neurobiology of Approach Avoidance Training in Depression
Status: Enrolling
Updated:  8/31/2017
University of California, San Diego; Psychiatry Clinical Research
mi
from
San Diego, CA
The Neurobiology of Approach Avoidance Training in Depression
The Neurobiology of Approach Avoidance Training in Depression
Status: Enrolling
Updated: 8/31/2017
University of California, San Diego; Psychiatry Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Pharmacokinetic Study of Bupropion Hydrochloride Products With Different Release Patterns
Pharmacokinetic Study of Bupropion Hydrochloride Products With Different Release Patterns
Status: Enrolling
Updated:  9/1/2017
University of Michigan
mi
from
Ann Arbor, MI
Pharmacokinetic Study of Bupropion Hydrochloride Products With Different Release Patterns
Pharmacokinetic Study of Bupropion Hydrochloride Products With Different Release Patterns
Status: Enrolling
Updated: 9/1/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Does Dual Therapy Hasten Antidepressant Response?
Combining Antidepressants to Hasten Remission From Depression
Status: Enrolling
Updated:  9/5/2017
New York State Psychiatric Institute
mi
from
New York, NY
Does Dual Therapy Hasten Antidepressant Response?
Combining Antidepressants to Hasten Remission From Depression
Status: Enrolling
Updated: 9/5/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Does Dual Therapy Hasten Antidepressant Response?
Combining Antidepressants to Hasten Remission From Depression
Status: Enrolling
Updated:  9/5/2017
University of Ottawa, Institute of Mental Health Research
mi
from
Ottawa,
Does Dual Therapy Hasten Antidepressant Response?
Combining Antidepressants to Hasten Remission From Depression
Status: Enrolling
Updated: 9/5/2017
University of Ottawa, Institute of Mental Health Research
mi
from
Ottawa,
Click here to add this to my saved trials
Functional MRI Before and After Treatment for Depression
Functional MRI Before and After Treatment for Depression
Status: Enrolling
Updated:  9/12/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Functional MRI Before and After Treatment for Depression
Functional MRI Before and After Treatment for Depression
Status: Enrolling
Updated: 9/12/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?
A Pathophysiological Study to Determine if Enhancing Glutamate Transporter Function Produces Antidepressant Effects in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?
A Pathophysiological Study to Determine if Enhancing Glutamate Transporter Function Produces Antidepressant Effects in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Phoenix, AZ
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Little Rock, AR
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Orange, CA
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Denver, CO
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Norwich, CT
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Norwich, CT
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Jacksonville, FL
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Orlando, FL
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Winter Park, FL
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Winter Park, FL
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Springfield, IL
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Springfield, IL
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Rockville, MD
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Weymouth, MA
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Weymouth, MA
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Willingboro, NJ
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Willingboro, NJ
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Brooklyn, NY
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Dayton, OH
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Garfield Heights, OH
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Garfield Heights, OH
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Portland, OR
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Salem, OR
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Salem, OR
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Emmaus, PA
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Emmaus, PA
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Philadelphia, PA
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Columbia, SC
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Columbia, SC
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Austin, TX
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Dallas, TX
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
San Antonio, TX
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Charlottesville, VA
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Milwaukee, WI
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Penticton,
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Penticton,
Click here to add this to my saved trials
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  9/12/2017
GSK Investigational Site
mi
from
Saint Charles, MO
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 9/12/2017
GSK Investigational Site
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Cognitive Behavioral Treatment of Depression in ESRD Patients on Dialysis
Status: Enrolling
Updated:  9/14/2017
Parkside Hemodialysis
mi
from
Brooklyn, NY
Cognitive Behavioral Treatment of Depression in ESRD Patients on Dialysis
Status: Enrolling
Updated: 9/14/2017
Parkside Hemodialysis
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression
Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression
Status: Enrolling
Updated:  9/18/2017
New York State Psychiatric Institute
mi
from
New York, NY
Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression
Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression
Status: Enrolling
Updated: 9/18/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women
Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women
Status: Enrolling
Updated:  9/19/2017
Massachusetts General Hospital
mi
from
Boston, MA
Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women
Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women
Status: Enrolling
Updated: 9/19/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression
A Placebo Controlled Trial of Mirtazapine for Patients With Depression and Cocaine Dependence
Status: Enrolling
Updated:  9/25/2017
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression
A Placebo Controlled Trial of Mirtazapine for Patients With Depression and Cocaine Dependence
Status: Enrolling
Updated: 9/25/2017
Research Foundation for Mental Hygiene, Inc.
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Pharmacology Research Institute (PRI)
mi
from
Newport Beach, CA
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Pharmacology Research Institute (PRI)
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Bioscience Research, Llc
mi
from
Mount Kisco, NY
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
The Medical Research Network, LLC
mi
from
New York, NY
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Fingerlakes Clinical Research
mi
from
Rochester, NY
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Fingerlakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Lehigh Center for Clinical Research
mi
from
Allentown, PA
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Northwest Clinical Research Center
mi
from
Bellevue, WA
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated:  9/25/2017
Chicago Research Center, Inc
mi
from
Chicago, IL
A Study of Intermittent Doses of CERC-301 in MDD
A Randomized, Double-Blind, Placebo-Controlled Study of Intermittent Doses of CERC-301 in the Treatment of Subjects With Severe Depression Despite Antidepressant Treatment
Status: Enrolling
Updated: 9/25/2017
Chicago Research Center, Inc
mi
from
Chicago, IL
Click here to add this to my saved trials